Mr. Patrick Montpetit is Chief Financial Officer, Vice President of Immunotec Inc. Prior to joining the Company, Mr. Montpetit held a number of senior financial management positions, most recently as VicePresident, Finance and Chief Financial Officer of Bioniche Life Sciences Inc . His experience over the past fifteen years was in the life sciences and biopharmaceutical industries where he was involved in raising over 250 million dollars in growth capital. During this time, he served as Chairman of the Quebec Biotechnology Association and as a director of the Montreal InVivo organization. Prior to Bioniche, Mr. Montpetit was the Director of Finance, Administration, Commercial Agreements and Alliances with DSM Biologics Inc., a multinational pharmaceutical company and the Netherlands. Mr. Montpetit is a Chartered Accountant combined with a specialty in corporate finance from the Canadian Institute of Chartered Accountants.
The company has return on total asset (ROA) of 4.83 % which means that it generated profit of $4.83 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 5.35 % meaning that it generated $5.35 on every $100 dollars invested by stockholders.
The company has accumulated 2.05 M in total debt with debt to equity ratio (D/E) of 0.17 which may suggest the company is not taking enough advantage from borrowing. Immunotec Inc has Current Ratio of 1.39 which is within standard range for the sector.
Immunotec Inc., a network marketing company, manufactures and sells natural health solutions and dietary supplements in Canada, the United States, Europe, Mexico, and the Caribbean. Immunotec Inc [IMM] is traded on TSX Venture Exchange in Canada. It is located in VaudreuilDorion, QC JV V and employs 13 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory